Cystic Fibrosis Model Development Services
Ace Therapeutics is a specialized preclinical CRO committed to advancing respiratory disease research. Our cystic fibrosis (CF) model development services are designed to support pharmaceutical companies, biotech firms, and academic institutions in evaluating novel therapeutic candidates. We understand that each research program has unique requirements; therefore, we do not offer off-the-shelf models but instead collaborate closely with clients to develop custom CF models that accurately reflect human disease pathology. From cellular assays to complex in vivo systems, our team provides comprehensive solutions to facilitate your preclinical efficacy, pharmacokinetic, and safety studies.
Cystic fibrosis is caused by mutations in the CFTR gene, leading to dysfunctional chloride channels and multi-organ pathology. The heterogeneous nature of CFTR mutations (e.g., F508del, G551D, class I–VI mutations) demands models that closely mimic specific genetic backgrounds and disease phenotypes. Custom-developed models ensure that your preclinical data are relevant, reproducible, and translatable. By leveraging advanced gene-editing technologies and disease-relevant platforms, Ace Therapeutics enables you to assess drug candidates in systems that faithfully recapitulate CF pathophysiology.
We offer a continuum of custom model development—from initial concept to fully characterized systems ready for compound testing. The table below outlines the major model types we can develop, along with their key features and typical applications.
| Model Type | Description | Key Features |
| CFTR-Mutant Cell Lines | Immortalized or primary cells (e.g., bronchial epithelial cells) engineered with specific CFTR mutations via CRISPR/Cas9. | |
| iPSC-Derived Airway Epithelial Cells | Induced pluripotent stem cells from CF patients differentiated into functional airway epithelium. | |
| Intestinal & Airway Organoids | 3D organoid cultures derived from patient biopsies or iPSCs, retaining CFTR-mediated swelling/function. | |
| CFTR Knockout/Mutant Mice | Transgenic rodent models with targeted CFTR mutations (e.g., F508del, G542X) on defined genetic backgrounds. | |
| Larger Animal Models (e.g., Pig, Ferret) | Genetically engineered large animals recapitulating human CF lung and pancreatic pathology. |
Note: All models are custom-generated based on your mutation of interest, species preference, and required endpoints. We work with you to define the precise genetic modification and validate each model using state-of-the-art assays.
Once a CF model is established, Ace Therapeutics offers a comprehensive suite of downstream services to support your drug development pipeline. These studies can be performed as standalone projects or integrated into a seamless workflow.
Model Characterization & Validation
Efficacy Studies
Pharmacokinetic / Pharmacodynamic (PK/PD) Studies
Safety & Toxicology Assessments
Biomarker Analysis
Custom model development is a partnership. At Ace Therapeutics, we are committed to providing scientifically rigorous, flexible, and transparent services that empower your preclinical research. Whether you need a simple cell-based assay or a complex large-animal efficacy study, our team is ready to collaborate.
What types of CFTR mutations can you model?
We can develop models for virtually any CFTR mutation, including the most common classes (F508del, G551D, G542X, etc.) as well as rare mutations. Using CRISPR/Cas9 or patient-derived cells, we introduce or correct specific mutations to create isogenic or disease-relevant systems.
How do you validate that the model recapitulates human CF pathology?
Validation includes multiple layers: genetic confirmation (sequencing), CFTR protein expression (Western blot/IHC), and functional assays such as Ussing chamber measurements of chloride transport, organoid swelling assays, and electrophysiological recordings. For animal models, we also assess histological changes and biomarkers of inflammation/infection.
What information do you need to initiate a custom model project?
We typically discuss your target mutation(s), desired model type (cell, organoid, or animal), species, and intended use (e.g., screening, efficacy, PK). A short summary of your research objectives helps us propose the most suitable approach and timelines.
Can you develop models for combination therapy testing?
Absolutely. Our models are well-suited for evaluating drug combinations, such as a corrector plus a potentiator, or a CFTR modulator with an anti-inflammatory agent. We can design multi-arm studies to assess additive or synergistic effects.
What is the typical timeline for generating a custom CF mouse model?
Timelines vary depending on the complexity of the genetic modification and breeding requirements. We will provide a project-specific estimate after initial consultation. Our goal is to deliver models efficiently while maintaining the highest quality standards.
How do you handle intellectual property arising from collaborative projects?
Ace Therapeutics respects client IP. We typically operate under a service agreement where all data and materials generated for you remain your property. Specific terms can be arranged to meet your institution's requirements.
Make Order
Experimental Scheme
Implementation
Conclusion
Ace Therapeutics is a preclinical research organization focused on respiratory diseases. We provide validated models and rigorous analysis services to support the development of novel therapeutics, from concept to preclinical insight.